Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Alcohol shown to act in same way as rapid antidepressants
Alcohol shown to act in same way as rapid antidepressants
In a study published in the current issue of the journal Nature Communications, researchers found that alcohol produces the same neural and molecular changes as drugs that have proven to be rapidly ef...
Pivotal Phase III Study Started With Vericiguat in Patients With Chronic Heart Failure
Pivotal Phase III Study Started With Vericiguat in Patients With Chronic Heart Failure
BERLIN, Germany I September 28, 2016 I Bayer announced today that the first patient was enrolled in VICTORIA, a pivotal Phase III clinical study led by Bayer’s collaboration partner MSD, which will ...
FDA approves Medtronic's 'artificial pancreas' for diabetes
FDA approves Medtronic's 'artificial pancreas' for diabetes
Medtronic Plc won U.
Amgen says cancer treatment missed endpoint in late-stage clinical trial
Amgen says cancer treatment missed endpoint in late-stage clinical trial
Amgen on Tuesday said a study testing the use of its multiple myeloma treatment Kyprolis in combination with other agents missed its primary endpoint after failing to show superiority in progression-f...
Poland raids major erectile dysfunction drug counterfeiter
Poland raids major erectile dysfunction drug counterfeiter
Police in Poland have come down hard on a ring they say had perhaps the world’s largest counterfeit Viagra operation.
Pfizer Has Abandoned Its Plan to Split Into Two Companies
Pfizer Has Abandoned Its Plan to Split Into Two Companies
U.
GW Pharma Attains 52-Week High on Positive Epidiolex Data
GW Pharma Attains 52-Week High on Positive Epidiolex Data
GW Pharmaceuticals plc’s shares are riding high after the company reported third consecutive positive phase III data on its lead cannabinoid pipeline candidate, Epidiolex, so far this year.
U.N. Calls Antibiotics in Food a Health Crisis on Par With AIDS
U.N. Calls Antibiotics in Food a Health Crisis on Par With AIDS
The CDC says 23,000 Americans die a year from drug-resistant bacteria.
Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
BOULDER, CO, USA I September 26, 2016 I Array BioPharma (ARRY) and Pierre Fabre today jointly announced top-line results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used with MEK1...
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
PALO ALTO, CA, USA I September 26, 2016 I Orbus Therapeutics Inc.
Mylan faces scrutiny over EpiPen profit data shown to Congress
Mylan faces scrutiny over EpiPen profit data shown to Congress
Mylan NV (MYL.
UK okays Alexion drug costing up to $2 million but wants price cut
UK okays Alexion drug costing up to $2 million but wants price cut
A new drug to treat a rare inherited bone disorder that was developed by Alexion Pharmaceuticals and could cost up to 1.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand